Heron Therapeutics Announces Board and Executive Compensation Changes
Ticker: HRTX · Form: 8-K · Filed: Apr 29, 2025 · CIK: 818033
| Field | Detail |
|---|---|
| Company | Heron Therapeutics, INC. /De/ (HRTX) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-of-directors
Related Tickers: HRTX
TL;DR
Heron Therapeutics (HRTX) filed an 8-K detailing board changes and executive comp adjustments.
AI Summary
Heron Therapeutics, Inc. announced on April 28, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company elected new directors and approved new compensatory arrangements for certain officers, details of which are filed as exhibits to this report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is routine and reports on standard corporate governance and compensation matters without indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- Heron Therapeutics, Inc. (company) — Registrant
- April 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-33221 (company_id) — Commission File Number
- 94-2875566 (ein) — I.R.S. Employer Identification No.
- 100 Regency Forest Drive, Suite 300, Cary, NC 27518 (address) — Address of principal executive offices
- (858) 251-440 (phone) — Registrant's telephone number
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of new directors, but the specific names and details of their election are provided in the exhibits.
What are the details of the compensatory arrangements for certain officers?
The filing states that compensatory arrangements for certain officers were approved, with the specific details included in the exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 28, 2025.
What is Heron Therapeutics, Inc.'s state of incorporation?
Heron Therapeutics, Inc. is incorporated in Delaware.
Where are Heron Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 100 Regency Forest Drive, Suite 300, Cary, NC 27518.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding HERON THERAPEUTICS, INC. /DE/ (HRTX).